Atnahs (Antigua BidCo) (PRIVATE.ATNAHSANTIG)

Overall impact
D (20)

Commentary

Atnahs (Antigua BidCo) is a below-average overall performer. With a 'D' rating of 20.2 for overall impact (bottom 10% of all companies), Atnahs (Antigua BidCo) ranks 161st out of 161 industry peers, behind Concrete Pumping, Yintech Investment, Mars Acquisition Corp. and 157 others, and ahead of and -3 others. On top material causes for Atnahs (Antigua BidCo)'s industry (Pharmaceuticals), Atnahs (Antigua BidCo) performs poorly in Quality Lifelong Education (34.6 score), Racial Justice and Civil Rights (5.3), Reduced Waste (13.9) and 67 other causes where it received a 'D' or 'F' score. Atnahs (Antigua BidCo) did not receive an 'A' rating on any cause.
Impact
Cause PRIVATE.ATNAHSANTIG
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Sector
Financials
Industry
Pharmaceuticals
Sub-industry
Investment Banking & Brokerage
SASB industry
Investment Banking & Brokerage
Share classes
PRIVATE.ATNAHSANTIG
Description
Atnahs (Antigua BidCo) is a UK-based pharmaceutical aggregator that acquires off‑patent, legacy branded generic medicines from larger pharmaceutical companies and is the parent/top entity of Atnahs Pharma UK Ltd.
Material causes
Ethos considers the following causes material for Atnahs (Antigua BidCo), based on its industry sub-industry Investment Banking & Brokerage. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.